#immunogenicity — Wednesday, July 08, 2026 (1 items)
| 0 | 💬 0 |
SBRT embedded in low-dose RT plus alphaPD-1 (immuno-EclipseRT, iERT) elicits CD8(+) T cell immunity against bulky tumors via an IFN-I/NK/DC axis.
(nature.com)
|
Nature Communications 2026-07-08 | #immunotherapy #radiotherapy #cancer #immunogenicity #transcriptomics |